Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

MR antagonists may improve skin health and wound healing, especially in aging.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Phloroglucinol may help improve hair loss by promoting hair growth and reducing oxidative stress.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

RADA-PDGF2 hydrogel speeds up wound healing and is safe for use.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Choosing the right estroprogestin is crucial for effectively managing PCOS symptoms.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

Finasteride reduces movement issues in Parkinson's disease rats.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.